Cite
HARVARD Citation
Chen, L. et al. (n.d.). 85P Tislelizumab combined with apatinib and oxaliplatin plus S1 as neoadjuvant therapy for Borrmann IV large Borrmann III type and bulky N positive advanced gastric cancer: A single-arm multicenter trial (TAOS-3B-Trial). Immuno-oncology technology. p. . [Online].